Do antibiotic-impregnated catheters prevent infection in CSF diversion procedures? Review of the literature

Journal of Infection

Volumn 61, Issue 1, 2010, Pages 9-20

  Gutiérrez González, Raquel ^a   Boto, Gregorio R ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Antibiotic impregnated; Catheter; Cerebrospinal fluid; External ventricular drain; Infection; Shunt

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ELASTOMER; FUSIDIC ACID; MINOCYCLINE; OXACILLIN; PENICILLIN G; POLYMER; RIFAMPICIN; SPARFLOXACIN; SULFADIAZINE SILVER; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC IMPREGNATED CATHETER; ANTIMICROBIAL ACTIVITY; BRAIN VENTRICLE; CATHETER; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID SHUNTING; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; DEVICE INFECTION; DRUG SAFETY; HOSPITAL COST; HUMAN; INFECTION PREVENTION; REVIEW; RISK REDUCTION; BACTERIAL INFECTIONS; CATHETERIZATION; DISINFECTION; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERIZATION; CEREBROSPINAL FLUID SHUNTS; DISINFECTION; HUMANS;

EID: 77953810697     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.03.030     Document Type: Review

References (73)

1. Blount J.P., Campbell J.A., Haines S.J. Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 1993, 4:633-656.
2. Borgbjerg B.M., Gjerris F., Albeck M.J., Borgesen S.E. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995, 136:1-7.
3. George R., Leibrock L., Epstein M. Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 1979, 51:804-811.
4. Kestle J., Drake J., Milner R., Sainte-Rose C., Cinalli G., Boop F., et al. Long-term follow-up data from the shunt design trial. Pediatr Neurosurg 2000, 33:230-236.
5. Kestle J.R., Garton H.J., Whitehead W.E., Drake J.M., Kulkarni A.V., Cochrane D.D., et al. Management of shunt infections: a multicenter pilot study. J Neurosurg 2006, 105(Suppl. 3):177-181.
6. Lenfestey R.W., Smith P.B., Moody M.A., Clark R.H., Cotten C.M., Seed P.C., et al. Predictive value of cerebrospinal fluid parameters in neonates with intraventricular drainage devices. J Neurosurg 2007, 107(Suppl. 3):209-212.
7. Lyke K.E., Obasanjo O.O., Williams M.A., O'Brien M., Chotani R., Perl T.M. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis 2001, 33:2028-2033.
8. Schoenbaum S.C., Gardner P., Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975, 131:543-552.
9. Walters B.C., Hoffman H.J., Hendrick E.B., Humphreys R.P. Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984, 60:1014-1021.
10. Wang K.W., Chang W.N., Shih T.Y., Huang C.R., Tsai N.W., Chang C.S., et al. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcome. Jpn J Infect Dis 2004, 57:44-48.
11. Bayston R. Preliminary studies on the impregnation of silastic elastomers with antimicrobial substances. Devel Med Child Neurol Suppl 1976, 37:50-54.
12. Albanese A., De Bonis P., Sabatino G., Capone G., Marchese E., Vignati A., et al. Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochir (Wien) 2009, 151:1259-1263.
13. Aryan H.E., Meltzer H.S., Park M.S., Bennett R.L., Jandial R., Levy M.L. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 2005, 21:56-61.
14. Attenello F.J., Garces-Ambrossi G.L., Zaidi H.A., Sciubba D.M., Jallo G.I. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010, 66:284-289.
15. Eymann R., Chehab S., Strowitzki M., Steudel W.I., Kiefer M. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatrics 2008, 1:444-450.
16. Eymann R., Steudel W.I., Kiefer M. Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children - a retrospective analysis. Klin Padiatr 2009, 221:69-73.
17. Govender S.T., Nathoo N., van Deller J.R. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 2003, 99:831-839.
18. Gutiérrez-González R., Boto G.R., González N., Viudez I., Pérez-Zamarrón A., Rivero-Garvía M. Effect of antibiotic-impregnated catheters on the incidence of infection after cerebrospinal fluid shunting. Med Clin (Barc) 2008, 131:121-124.
19. Hampl J.A., Weitzel A., Bonk C., Kohnen W., Roesner D., Jansen B. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 2003, 31:109-111.
20. Hayhurst C., Cooke R., Williams D., Kandasamy J., O'Brien D.F., Mallucci C.L. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2008, 24:557-562.
21. Kan P., Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infection in children. Childs Nerv Syst 2007, 23:773-777.
22. Muttaiyah R., Ritchie S., John S., Mee E., Roberts S. Efficacy of antibiotic-impregnated external ventricular drain catheters. J Clin Neurosci 2010, 10.1016/j.jocn.2009.06.01.
23. Parker S.L., Attenello F.J., Sciubba D.M., Garces-Ambrossi G.L., Ahn E., Weingart J., et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 2009, 25:77-83.
24. Pattavilakom A., Xenos C., Bradfield O., Danks R.A. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 2007, 14:526-531.
25. Richards H.K., Seeley H.M., Pickard J.D. Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from de United Kingdom Shunt Registry. J Neurosurg Pediatr 2009, 4:389-393.
26. Ritz R., Roser F., Morgalla M., Dietz K., Tatagiba M., Will B.E. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007, 7:38.
27. Sciubba D.M., Stuart R.M., McGirt M.J., Woodworth G.F., Samdani A., Carson B., et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 2005, 103(Suppl. 2):131-136.
28. Sciubba D.M., Lin L., Woodworth G.F., McGirth M.J., Carson B., Jallo G.I. Factors contributing the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 2007, 22:E9.
29. Sciubba D.M., McGirt M.J., Woodworth G.F., Carson B., Jallo G.I. Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 2007, 23:867-871.
30. Sciubba D.M., Noggle J.C., Carson B.S., Jallo G.I. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus. Pediatr Neurosurg 2008, 44:91-96.
31. Sloffer C.A., Augspurger L., Wagenbach A., Lanzino G. Antimicrobial-impregnated external ventricular catheters: does the very low infection rate observed in clinical trials apply to daily clinical practice?. Neurosurgery 2005, 56:1041-1044.
32. Tamburrini G., Massimi L., Caldarelli M., Di Rocco C. Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien) 2008, 150:1049-1056.
33. Zabramski J.M., Whiting D., Darouiche R.O., Horner T.G., Olson J., Robertson C., et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003, 98:725-730.
34. Bayston R., Penny S.R. Excessive production of mucoid substance in staphylococcus SIIA: a possible factor in colonisation of holter shunts. Dev Med Child Neurol Suppl 1972, 27:25-28.
35. Donetz A.P., Harvey R.A., Greco R.S. Stability of antibiotics bound to politetrafluoroethylene with cationic surfactants. J Clin Microbiol 1984, 19:1-3.
36. Harvey R.A., Greco R.S. The noncovalent bonding of antibiotics to a politetrafluoroethylene-benzalkonium graft. Ann Surg 1981, 194:642-647.
37. Jagpal R., Greco R.S. Studies of a graphite-benzalkonium-oxacillin surface. Am Surg 1979, 45:774-779.
38. Modak S.M., Sampath L., Fox C.L., Benvenisty A., Nowygrod R., Reemstmau K. A new method for the direct incorporation of antibiotic in prosthetic vascular grafts. Surg Gynecol Obstet 1987, 164:143-147.
39. Moore W.S., Chvapil M., Seiffert G., Keown K. Development of an infection-resistant vascular prosthesis. Arch Surg 1981, 116:1403-1407.
40. Trooskin S.Z., Donetz A.P., Harvey R.A., Greco R.S. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985, 97:547-551.
41. Carr H.S., Wlodkowski T.J., Rozenkranz H.S. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob Agents Chemother 1973, 4:585-590.
42. Bach A., Böhrer H., Motsch J., Martin E., Geiss H.K., Sonntag H.G. Prevention of catheter-related infections by antiseptic bonding. J Surg Res 1993, 55:640-646.
43. Galiano K., Pleifer C., Engelhardt K., Brössner G., Lackner P., Huck C., et al. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol Res 2008, 30:285-287.
44. Raad I., Hachem R., Zermeno A., Dumo M., Bodey G.P. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 1996, 17:1055-1059.
45. Sampath L.A., Tambe S.M., Modak S.M. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001, 22:640-646.
46. Secer H.I., Kural C., Kaplan M., Kilic A., Duz B., Gonul E., et al. Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study. Pediatr Neurosurg 2008, 44:444-447.
47. Bayston R., Grove N., Siegel J., Lawellin D., Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989, 52:605-609.
48. Hampl J., Schierholz J., Jansen B., Aschoff A. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 1995, 133:147-152.
49. Kockro R.A., Hampl J.A., Jansen B., Peters G., Scheihing M., Giacomelli R., et al. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampicin-impregnated CSF shunt catheters. J Med Microbiol 2000, 49:441-450.
50. Kohnen W., Schaper J., Klein O., Tieke B., Jansen B. A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 1998, 287:147-156.
51. Kohnen W., Kolbenschlag C., Teske-Keiser S., Jansen B. Development of a long-lasting ventricular catheter impregnated with a combination of antibiotics. Biomaterials 2003, 24:4865-4869.
52. Schierholz J., Jansen B., Jaenicke L., Pulverer G. In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 1994, 15:996-1000.
53. Schierholz J.M., Pulverer G. Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol 1997, 286:107-123.
54. Raad I., Darouchie R., Hachem R., Sacilowski M.M., Bodey G.P. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995, 39:2397-2400.
55. Bayston R. The antibacterial effects of impregnated silastic and its possible applications in surgery. J Ped Surg 1997, 12:55-61.
56. Bayston R. The effect of antibiotic impregnation on the function of slit valves used to control hydrocephalus. Z Kinderchir 1980, 31:353-359.
57. Bayston R., Milner R.D. Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances. J Clin Pathol 1981, 34:1057-1062.
58. Bayston R., Zdroyewski V., Barsham S. Use of an in vitro model for studying the eradication of catheter colonisation by Staphylococcus epidermidis. J Infect 1988, 16:141-146.
59. Bayston R., Barsham S. Catheter colonisation: a laboratory model suitable for aetiological, therapeutic and preventive studies. Med Lab Sci 1988, 45:235-239.
60. Bayston R., Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997, 87:247-251.
61. Abed W.T., Alavijeh M.S., Bayston R., Shorvon S.D., Patsalos P.N. An evaluation of the epileptogenic properties of a rifampicin/clindamycin-impregnated shunt catheter. Br J Neurosurg 1994, 8:725-730.
62. Bayston R., Ashraf W., Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 2004, 53:778-782.
63. Pattavilakom A., Kotasnas D., Korman T.M., Xenos C., Danks A. Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 2006, 58:930-935.
64. Darouchie R.O., Raad I.I., Heard S.O., Thornby J.I., Wenker O.C., Gabrielli A., et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999, 340:1-8.
65. Darouiche R.O., Smith J.A., Hanna H., Dhabuwala C.B., Steiner M.S., Babaian R.J., et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999, 54:976-981.
66. Leon C., Ruiz-Santana S., Rello J., de la Torre M.V., Valles J., Alvarez-Lerma F., et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004, 30:1891-1899.
67. Maki D.G., Cobb L., Garman J.K., Shapiro J.M., Ringer M., Helgerson R.B. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988, 85:307-314.
68. Schumm K., Lam T.B. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review. Neurourol Urodyn 2008, 27:738-746.
69. Veenstra D.L., Saint S., Saha S., Lumley T., Sullivan S.D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999, 281:261-267.
70. Izci Y., Secer H., Akay C., Gonul E. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus. Neurol Res 2008, 31:234-237.
71. Kaufmann A.M., Lye T., Redekop G., Brevner A., Hamilton M., Kozey M., et al. Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol Sci 2004, 31:506-510.
72. Lackner P., Beer R., Broessner G., Helbok R., Galiano K., Pleifer C., et al. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008, 8:360-365.
73. Stevens E.A., Palavecino E., Sherertz R.J., Shihabi Z., Couture D.E. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. J Neurosurg 2009, 10.3171/2009.10.JNS09565.